NewGenIvf Group Limited
NIVF
$1.81
$0.0623.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -16.18% | -0.35% | 25.64% | 25.64% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -16.18% | -0.35% | 25.64% | 25.64% | |
| Cost of Revenue | -44.47% | -11.00% | 69.82% | 69.82% | |
| Gross Profit | 173.93% | 17.47% | -31.48% | -31.48% | |
| SG&A Expenses | 4,635.65% | -3.74% | -24.43% | -24.43% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 83.62% | -8.62% | 22.30% | 22.30% | |
| Operating Income | -567.83% | 110.00% | 1.98% | 1.98% | |
| Income Before Tax | -283.59% | -128.08% | -31.46% | -31.46% | |
| Income Tax Expenses | -481.48% | -- | -- | -- | |
| Earnings from Continuing Operations | -114.76% | -128.08% | -2.38% | -2.38% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -19.68% | 294.44% | -112.43% | -112.43% | |
| Net Income | -132.24% | -119.41% | -28.85% | -28.85% | |
| EBIT | -567.83% | 110.00% | 1.98% | 1.98% | |
| EBITDA | -521.89% | 112.58% | -0.36% | -0.36% | |
| EPS Basic | -125.34% | -- | -- | -- | |
| Normalized Basic EPS | -318.07% | -- | -- | -- | |
| EPS Diluted | -125.40% | -- | -- | -- | |
| Normalized Diluted EPS | -318.07% | -- | -- | -- | |
| Average Basic Shares Outstanding | 27.28% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 27.28% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |